NEW YORK (GenomeWeb) – Becton Dickinson's BD Life Sciences segment said today that it has obtained CE mark for the BD Max CT/GC/TV and CT/GC assays. 

The assays are for detecting Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis from a single specimen in one run. Urine samples can be used for testing, as well as self-collected vaginal swabs and clinician-collected endocervical swabs, BD said. Once loaded onto the BD Max platform, results can be generated in less than three hours. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.